SCHEMBL23079765

SCHEMBL23079765

c1ccc2oc(-c3ccc(-c4nc(-c5ccc(-c6nc7ccccc7o6)cc5)nc(-c5cccc6c5sc5ccccc56)n4)cc3)nc2c1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 6/20 0.49
RAB9A P51151 5/20 0.49
MEN1 O00255 2/20 0.49
KMT2A Q03164 2/20 0.49
ATM Q13315 1/20 0.49
ALDH1A1 P00352 5/20 0.46
KDM4E B2RXH2 4/20 0.46
HPGD P15428 4/20 0.46
SMN1; SMN2 Q16637 3/20 0.46
TP53 P04637 3/20 0.46
HSD17B10 Q99714 3/20 0.46
MAPT P10636 3/20 0.44
LMNA P02545 1/20 0.44
GAA P10253 1/20 0.44
NFKB1 P19838 1/20 0.44
STAT1 P42224 1/20 0.44
GFER P55789 1/20 0.44
NFKB2 Q00653 1/20 0.44
RELA Q04206 1/20 0.44
ALOX5 P09917 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22736056 0.92 NPC1 (0.42) NPC1RAB9AMEN1KMT2AATM
SCHEMBL22736051 0.92 KDM4E (0.44) NPC1RAB9AMEN1KMT2AATM
SCHEMBL21890967 0.91 ALDH1A1 (0.43) NPC1RAB9AMEN1KMT2AATM
SCHEMBL8512669 0.90 NPC1 (0.50) NPC1RAB9AMEN1KMT2AATM
SCHEMBL22736067 0.90 NPC1 (0.40) NPC1RAB9AMEN1KMT2AATM
SCHEMBL22736405 0.90 NPC1 (0.40) NPC1RAB9AMEN1KMT2AATM
SCHEMBL22736050 0.90 KDM4E (0.43) NPC1RAB9AMEN1KMT2AATM
SCHEMBL22736565 0.90 KDM4E (0.43) NPC1RAB9AMEN1KMT2AATM
SCHEMBL22177629 0.89 ALDH1A1 (0.40) NPC1RAB9AMEN1KMT2AATM
SCHEMBL9603887 0.89 NPC1 (0.49) NPC1RAB9AMEN1KMT2AATM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210070717-A1 ORGANIC COMPOUND BASED ON TRIAZINE AND BENZOXAZOLE AND APPLICATION THEREOF IN ORGANIC ELECTROLUMINESCENT DEVICE JIANGSU SUNERA TECHNOLOGY CO., LTD. (CN) 2021-03-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210070717-A1 ORGANIC COMPOUND BASED ON TRIAZINE AND BENZOXAZOLE AND APPLICATION THEREOF IN ORGANIC ELECTROLUMINESCENT DEVICE OCIAD1, EED, OCIAD2 NPC1 3199/4885RAB9A 3258/4885MEN1 4875/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.